FDA Inspection 1260094 — Stephen Stripling, M.D.
The FDA completed an inspection of Stephen Stripling, M.D. on Jan 30, 2025 in Summerville, SC. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Jan 30, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Bioresearch Monitoring
- Location
- Summerville, SC (United States)
Additional Details
Clinical Investigator (CI)